NovaBridge Biosciences (NBP) Net Income towards Common Stockholders (2019 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$72.9 million in Q4 2025.

• Quarterly Net Income towards Common Stockholders changed N/A year-over-year to -$72.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$88.3 million (down 284.21% YoY) and the FY2024 annual result came in at $27.5 million, up 113.3% from the prior year.
• Net Income towards Common Stockholders declined to -$72.9 million in Q4 2025 per NBP's latest filing, from -$6.8 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $34.4 million in Q2 2024 and bottomed at -$72.9 million in Q4 2025.
• The 3-year median for Net Income towards Common Stockholders is -$4.3 million (2025), against an average of -$890875.0.
• Peak annual rise in Net Income towards Common Stockholders reached 54.33% in 2025, while the deepest fall reached 133.32% in 2025.
• Tracing NBP's Net Income towards Common Stockholders over 3 years: stood at $33.3 million in 2023, then plunged by 38.38% to $20.5 million in 2024, then sank by 455.56% to -$72.9 million in 2025.
• Per Business Quant, the three latest NBP Net Income towards Common Stockholders figures stand at -$72.9 million (Q4 2025), -$6.8 million (Q3 2025), and -$5.5 million (Q2 2025).

Peer Comparison